AZ’s COVID-19 Drug to Be Reviewed with Priority if Filed in Japan: Senior Vice Minister

Medical Associations, Patient Group Seek Early Commercialization of AstraZeneca’s COVID-19 Antibody Cocktail (Courtesy of Kozo Akino’s Office) Japan will review AstraZeneca’s long-acting antibody cocktail AZD7442 for COVID-19 on a priority basis if it is filed for Japanese regulatory approval, senior...read more